12 December 2023

    RDAF newsletter – December 2023

    30 June 2023

    RDAF newsletter – June 2023

    16 September 2022

    RDAF position statement on KVV/KLV revision

    22 December 2021

    RDAF activities in 2021 and outlook for 2022

    19 April 2021

    Webinar report – Access to diagnosis and treatment of rare diseases in Switzerland Current status, challenges and initiatives (25 March 2021)

    25 June 2020

    Multi-stakeholder workshop report – Registries for rare diseases in Switzerland (8 April 2020)

    21 November 2023

    RDAF statement on the KVV / KLV revision

    17 October 2022

    Joint statement on the KVV/OAMal and KLV/OPAS revision

    29 June 2022

    RDAF newsletter – June 2022

    06 October 2021

    RDAF statement on the Federal Council report on rare diseases

    19 March 2021

    RDAF statement for the public consultation on the adjustment of various ordinances which are needed to implement the revised Swiss Invalidity Insurance

    08 November 2023

    Multi-stakeholder workshop report – Post-marketing registries for rare diseases

    03 October 2022

    The Rare Disease Action Forum (RDAF) advocates for a fair and rapid access to high-quality treatment for patients with rare diseases in Switzerland.

    26 April 2022

    Multi-stakeholder workshop report – Market access for orphan drugs in Switzerland

    14 July 2021

    Report of the RDAF Multi-Stakeholder Workshop on Registries for Rare Diseases

    10 December 2020

    RDAF statement for the public consultation on he revision of the Federal Health Insurance Act concerning package 2 of the cost containment measures